Diagnostic criteria for hemolytic jaundice in newborns
Hemolytic jaundice in newborns is diagnosed based on prenatal diagnostic tests, postnatal clinical manifestations, postnatal complete blood count (CBC), postnatal urinalysis, and postnatal measurement of carbon monoxide levels, among others. The specific details are as follows:
1. Prenatal Diagnostic Tests
Amniotic fluid examination may reveal greenish-yellow amniotic fluid, suggesting significant fetal hemolysis. Higher bilirubin levels in the amniotic fluid indicate a greater likelihood of fetal hemolysis. If X-ray imaging shows widened translucent bands in fetal soft tissues and poor limb flexion, and ultrasound reveals pleural or abdominal effusions in the fetus, hemolytic jaundice can be diagnosed.
2. Postnatal Clinical Manifestations
Hemolytic jaundice commonly causes symptoms such as abdominal pain, skin itching, weight changes, and fever. In acute cases, symptoms may include nausea, vomiting, and general fatigue.
3. Postnatal Complete Blood Count (CBC)
A peripheral blood test after birth may show low hemoglobin levels and increased reticulocyte count, which are indicative of hemolytic jaundice in newborns.
4. Postnatal Urinalysis
Urinalysis in newborns typically shows positive urobilinogen and negative bilirubin in the urine.
5. Postnatal Carbon Monoxide Measurement
Elevated levels of carbon monoxide in the newborn's exhaled breath suggest abnormally increased bilirubin production, indicating possible hemolytic jaundice.
If a newborn shows any signs of discomfort, parents should promptly seek medical attention and follow standardized treatment under a physician’s guidance to facilitate recovery.